BDBM191763 US10669227, Compound Curcumin::US11608309, Compound Curcumin::US9187397, 1::US9187406, Curcumin::curcumin

SMILES COc1cc(\C=C\C(=O)CC(=O)\C=C\c2ccc(O)c(CO)c2)ccc1O

InChI Key InChIKey=UAVJPMNEDOIHEI-YPCIICBESA-N

Data  13 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 13 hits for monomerid = 191763   

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Stc.Unm

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  8.20E+3nMAssay Description:The NF-kB activities of curcumin and analogs were determined by a cellular firefly luciferase assay. This assay utilized a commercially available cel...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetNeutrophil collagenase(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  1.40E+4nMT: 37°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetMatrix metalloproteinase-9(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  2.90E+4nMT: 37°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


Target72 kDa type IV collagenase(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  8.50E+4nMT: 37°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCollagenase 3(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  1.10E+5nMT: 37°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetNeutrophil collagenase(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  1.40E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCollagenase 3(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  1.10E+5nMAssay Description:Table 10: The efficacy of MMP-2 inhibition was as follows: compound 6>compound 7>compound 8. Although compound 6 showed similar efficacy as curcumin ...More data for this Ligand-Target Pair
In DepthDetails US Patent


Target72 kDa type IV collagenase(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  8.50E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCollagenase 3(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  1.10E+5nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetNeutrophil collagenase(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  1.40E+4nMAssay Description:Table 1 shows the IC50 of curcumin, compound 1, and compound 2, compared to a standard Zn++ binding & MMPI (matrix metalloproteinase inhibitor), 1,10...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetMatrix metalloproteinase-9(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  2.90E+4nMAssay Description:Table 1 shows the IC50 of curcumin, compound 1, and compound 2, compared to a standard Zn++ binding & MMPI (matrix metalloproteinase inhibitor), 1,10...More data for this Ligand-Target Pair
In DepthDetails US Patent


Target72 kDa type IV collagenase(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  8.50E+4nMAssay Description:Table 10: The efficacy of MMP-2 inhibition was as follows: compound 6>compound 7>compound 8. Although compound 6 showed similar efficacy as curcumin ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetMatrix metalloproteinase-9(Human)
The Research Foundation of State University of New York

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)
Affinity DataIC50:  2.90E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails US Patent